Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Neximmune, Inc. (NEXI)
:NEXI
Holding NEXI?
Track your performance easily
NEXI Stock Chart & Stats
Day’s Range― - ―
52-Week Range$0.10 - $28.69
Previous CloseN/A
Volume4.35K
Average Volume (3M)13.44K
Market Cap
$195.25K
Enterprise Value$1.37M
Total Cash (Recent Filing)$12.06M
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)―
Beta1.63
Next EarningsN/A
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-244.27
Shares Outstanding1,394,671
10 Day Avg. Volume14,542
30 Day Avg. Volume13,443
Standard Deviation0.92
R-Squared0.00981
Alpha-0.05
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)0.00
P/FCF Ratio0.00
Enterprise Value/Market Cap6.99
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/Ebitda-0.07
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
NexImmune News
PremiumCompany Announcements
NexImmune Dissolution Progresses with New Sole President
PremiumCompany Announcements
NexImmune Announces Leadership Shift in Financial Management
PremiumCompany Announcements
NexImmune Announces New Offerings in Recent Press Release
PremiumCompany Announcements
NexImmune Delays Liquidation Vote for Financing Review
PremiumCompany Announcements
NexImmune Equity Sales: Unregistered Securities and Private PlacementPremiumCompany Announcements
NexImmune Secures Funding Through Equity and Warrant Sales
PremiumCompany Announcements
NexImmune Ends Stock Sale Agreement, Raises $5.1 MillionOwnership Overview
<0.01% Insiders
0.36% Mutual Funds
7.35% Other Institutional Investors
92.29% Public Companies and
Individual Investors
Risk Analysis
Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy
NEXI FAQ
What was Neximmune, Inc.’s price range in the past 12 months?
Neximmune, Inc. lowest stock price was $0.10 and its highest was $28.69 in the past 12 months.
What is Neximmune, Inc.’s market cap?
Neximmune, Inc.’s market cap is $195.25K.
When is Neximmune, Inc.’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were Neximmune, Inc.’s earnings last quarter?
Neximmune, Inc. released its earnings results on May 13, 2024. The company reported -$2.461 earnings per share for the quarter, missing the consensus estimate of N/A by -$2.461.
Is Neximmune, Inc. overvalued?
According to Wall Street analysts Neximmune, Inc.’s price is currently Overvalued.
Does Neximmune, Inc. pay dividends?
Neximmune, Inc. does not currently pay dividends.
What is Neximmune, Inc.’s EPS estimate?
Neximmune, Inc.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Neximmune, Inc. have?
Neximmune, Inc. has 1,394,671 shares outstanding.
What happened to Neximmune, Inc.’s price movement after its last earnings report?
Neximmune, Inc. reported an EPS of -$2.461 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went down -8.197%.
Which hedge fund is a major shareholder of Neximmune, Inc.?
Currently, no hedge funds are holding shares in NEXI
---
Company Description
Neximmune, Inc.
NexImmune Inc is a clinical-stage biotechnology company engaged in developing immunotherapy to employ body's T cells to generate immune response that mimics natural biology. Its creates therapies with curative potential for patients with cancer and other life-threatening immune-mediated diseases.
---
Technical Analysis
Adaptimmune Therapeutics
―
Immutep
―
AlloVir
―
Medicinova
―
Alaunos Therapeutics
―
RegenXBio
―
---